Vigil Neuroscience’s $90 Million Series B Financing

Vigil Neuroscience’s $90 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience.Vigil Neuroscience, a biotechnology company harnessing the power of microglia…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here